• Global Hemp Group (GHG) and Revitalize Earth are updating the reverse-takeover transaction
  • Revitalize Earth focuses on cutting-edge agriculture and plant-based medicines, ensuring quality
  • Revitalize Earth is also looking to expand its footprint of medical and recreational cannabis products within the Canadian and European market
  • Revitalize Earth is looking to establish testing laboratories under license from governments in Thailand, Costa Rica, and Portugal
  • Global Hemp Group (GHG) is focused on executing a multi-phased strategy to become a leader in the industrial hemp industry in the United States
  • Global Hemp Group (GHG) is unchanged today, trading at C$0.02 as of Sep 21, 2:00 pm ET

Global Hemp Group (GHG) and Revitalize Earth are updating the reverse-takeover transaction.

The parties are amending their binding Letter of Intent to extend the due diligence period to October 31, 2022, and the closing of the definitive agreement and underlying transactions to October 31, 2022. Closing the contemplated listing on the CSE no later than March 31, 2023.

Revitalize Earth is in the process of completing an audit of its financial statements.

In the meantime, trading of GHG common shares will remain halted until the company receives shareholder approval by way of written consent.

Revitalize Earth focuses on cutting-edge agriculture and plant-based medicines, ensuring quality with all aspects of the business from seed to sale. Revitalize Earth uses science and the latest technologies to produce the most effective products and solutions. Revitalize Earth has partnered with a number of organic farms in California to ensure the quality of flower for their raw material. Their e-commerce platform averaged $1,150,000 in gross sales per month over the last 5 months.

Revitalize Earth is also looking to expand its footprint of medical and recreational cannabis products within the Canadian market by emulating its online dispensary model in Canada. In addition, adding other verticals in the sector, such as supplying cannabis pre-rolls, edibles, and a range of Belgian chocolates infused with psilocybin to the wholesale sector.

On a wider geographic level, Revitalize Earth has acquired a 1,500-acre parcel of land in Portugal to cater to the European market, which is just beginning to see sales of CBD, with Germany and Greece now offering medical cannabis products with high levels of THC for medical use.

Revitalize Earth is in the process of getting a license in the UK to supply the General Practitioners. They hold a license which allows them to prescribe medical cannabis to patients where they think it would be beneficial as a treatment.

Revitalize Earth is looking to establish testing laboratories under license from governments in Thailand, Costa Rica, and Portugal. The labs would be for the testing of cannabis under government supervision to establish THC values as well as collating valuable data from the plant and users.

Revitalize Earth is looking to expand its marketing reach into hemp-derived products in the future, using its waste materials for hempcrete and bioplastics. Global Hemp Group will help expand this market. The company is looking at the dietary use of hemp, such as hemp milk.

Global Hemp Group (GHG) is focused on executing a multi-phased strategy to become a leader in the industrial hemp industry in the United States. The company is headquartered in Vancouver, British Columbia. The current phase of the strategy focuses on the development of “sustainable” and “green” value-added industrial hemp products utilizing the processing of the entirety of the hemp plant for multi-merchantable applications.

Global Hemp Group (GHG) is unchanged today, trading at C$0.02 as of Sep 21, 2:00 pm ET.


More From The Market Online

Odd Burger to add 40 locations in Florida

Odd Burger (TSXV:ODD) will develop 40 new locations in Florida over the next eight years, with its sights set on further U.S. expansion.

Tilray Brands seeks US$250M for U.S. cannabis expansion

Global cannabis stock Tilray Brands (TSX:TLRY) intends to raise up to US$250 million to fund its U.S. expansion plan.

The Market Online’s Weekly Cannabis Report – May 17, 2024

This international biopharmaceutical company revealed it has completed the retrospective observational real-world evidence study.